Skip to main content
. Author manuscript; available in PMC: 2014 Apr 1.
Published in final edited form as: Clin Cancer Res. 2013 Feb 5;19(7):1806–1815. doi: 10.1158/1078-0432.CCR-12-2764

Figure 3. Biodistribution of MSV/siRNA.

Figure 3

SKOV3ip2 tumor mice were administrated i.v. with Dylight-MSV/Cy3-siRNA, and sacrificed 12, 24, 72, 120, and 168 hours later (n=3). Major organs and tumor tissues were collected, and fluorescent intensities from individual samples were measured. A, Dylight fluorescent intensity. B, Cy3 fluorescent intensity.

HHS Vulnerability Disclosure